Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124664525 | 12466452 | 5 | F | 20160511 | 20160714 | 20160615 | 20160718 | EXP | DE-ROCHE-1774572 | ROCHE | 84.47 | YR | F | Y | 50.00000 | KG | 20160718 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124664525 | 12466452 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | 0.5 MG, UNK, 1 SEPARATE DOSE | U | S2050C,S2046A,S2044D | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||
| 124664525 | 12466452 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | 0.5 ML, UNK, 1 SEPARATE DOSE | U | S2050C,S2046A,S2044D | 125156 | .5 | ML | SOLUTION FOR INJECTION | |||||
| 124664525 | 12466452 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | 0.5 ML, UNK, 1 SEPARATE DOSE | U | S2050C,S2046A,S2044D | 125156 | .5 | ML | SOLUTION FOR INJECTION | |||||
| 124664525 | 12466452 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | 0.5 ML, UNK, 1 SEPARATE DOSE | U | S2050C,S2046A,S2044D | 125156 | .5 | ML | SOLUTION FOR INJECTION | |||||
| 124664525 | 12466452 | 5 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Unknown | 50 MG, QD (MORNING) | 0 | 50 | MG | TABLET | QD | ||||||
| 124664525 | 12466452 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 20 MG, QD (MORNING) | 0 | 20 | MG | TABLET | QD | ||||||
| 124664525 | 12466452 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 5 MG, QD (MORNING) | 0 | 5 | MG | TABLET | QD | ||||||
| 124664525 | 12466452 | 8 | C | TOREM | TORSEMIDE | 1 | Unknown | 5 MG, BID (MORNING AND AFTERNOON) | 0 | 5 | MG | TABLET | BID | ||||||
| 124664525 | 12466452 | 9 | C | AQUAPHOR | PETROLATUM | 1 | Unknown | 10 MG, QD (MORNING) | 0 | 10 | MG | TABLET | QD | ||||||
| 124664525 | 12466452 | 10 | C | METAMIZOLE SODIUM | METAMIZOLE SODIUM | 1 | Unknown | (MORNING, AFTERNOON AND EVENING) | 0 | 40 | GTT | TABLET | TID | ||||||
| 124664525 | 12466452 | 11 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
| 124664525 | 12466452 | 12 | C | VALORON N | NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE | 1 | Unknown | 1 DF, BID (MORNING AND EVENING) | 0 | 1 | DF | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124664525 | 12466452 | 1 | Macular oedema |
| 124664525 | 12466452 | 2 | Retinal vein occlusion |
| 124664525 | 12466452 | 5 | Product used for unknown indication |
| 124664525 | 12466452 | 6 | Product used for unknown indication |
| 124664525 | 12466452 | 7 | Product used for unknown indication |
| 124664525 | 12466452 | 8 | Product used for unknown indication |
| 124664525 | 12466452 | 9 | Product used for unknown indication |
| 124664525 | 12466452 | 10 | Product used for unknown indication |
| 124664525 | 12466452 | 11 | Product used for unknown indication |
| 124664525 | 12466452 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124664525 | 12466452 | HO |
| 124664525 | 12466452 | DE |
| 124664525 | 12466452 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124664525 | 12466452 | Acute kidney injury | |
| 124664525 | 12466452 | Acute myocardial infarction | |
| 124664525 | 12466452 | Aortic arteriosclerosis | |
| 124664525 | 12466452 | Aortic stenosis | |
| 124664525 | 12466452 | Arteriosclerosis | |
| 124664525 | 12466452 | Ascites | |
| 124664525 | 12466452 | Bone density decreased | |
| 124664525 | 12466452 | Cardiac imaging procedure abnormal | |
| 124664525 | 12466452 | Diastolic dysfunction | |
| 124664525 | 12466452 | Ejection fraction abnormal | |
| 124664525 | 12466452 | Emphysema | |
| 124664525 | 12466452 | Faecaloma | |
| 124664525 | 12466452 | General physical condition abnormal | |
| 124664525 | 12466452 | General physical health deterioration | |
| 124664525 | 12466452 | Hepatic vein dilatation | |
| 124664525 | 12466452 | Hepatomegaly | |
| 124664525 | 12466452 | Hypokinesia | |
| 124664525 | 12466452 | Hypotension | |
| 124664525 | 12466452 | Inflammation | |
| 124664525 | 12466452 | Kyphosis | |
| 124664525 | 12466452 | Left ventricular dysfunction | |
| 124664525 | 12466452 | Left ventricular failure | |
| 124664525 | 12466452 | Mitral valve incompetence | |
| 124664525 | 12466452 | Oedema peripheral | |
| 124664525 | 12466452 | Osteochondrosis | |
| 124664525 | 12466452 | Pleural effusion | |
| 124664525 | 12466452 | Pneumonia | |
| 124664525 | 12466452 | Polycystic ovaries | |
| 124664525 | 12466452 | Portal vein dilatation | |
| 124664525 | 12466452 | Pulmonary fibrosis | |
| 124664525 | 12466452 | Pulmonary hypertension | |
| 124664525 | 12466452 | Scoliosis | |
| 124664525 | 12466452 | Sepsis | |
| 124664525 | 12466452 | Spinal flattening | |
| 124664525 | 12466452 | Spinal osteoarthritis | |
| 124664525 | 12466452 | Spondylolisthesis | |
| 124664525 | 12466452 | Tachyarrhythmia | |
| 124664525 | 12466452 | Tricuspid valve incompetence | |
| 124664525 | 12466452 | Urine output decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124664525 | 12466452 | 1 | 20160211 | 0 | ||
| 124664525 | 12466452 | 2 | 20160310 | 0 | ||
| 124664525 | 12466452 | 3 | 20160406 | 0 | ||
| 124664525 | 12466452 | 4 | 20160511 | 20160511 | 0 |